Modulation of cathepsin G expression in severe atopic dermatitis following medium-dose UVA1 phototherapy

BACKGROUND: During the last decade, medium-dose UVA1 phototherapy (50 J/cm(2)) has achieved great value within the treatment of severe atopic dermatitis (AD). The purpose of our study was to investigate to what extent UVA1 irradiation is able to modulate the status of protease activity by the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Breuckmann, Frank, von Kobyletzki, Gregor, Avermaete, Annelies, Kreuter, Alexander, Altmeyer, Peter, Gambichler, Thilo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC126230/
https://www.ncbi.nlm.nih.gov/pubmed/12204095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC126230/
https://www.ncbi.nlm.nih.gov/pubmed/12204095

Ejemplares similares